19832699_1|19832699|20434|#section_info|0:0|Approx. 7 nM (total) CsA yielded 50% inhibition of CyP-D (Figure 2A).|#main_body|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.62	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_2|19832699|20434|#section_info|0:0|Approx. 7 nM (total) CsA yielded 50% inhibition of CyP-D (Figure 2A).|#main_body|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.62	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_3|19832699|20434|#section_info|0:0|Accordingly, inhibition was analysed using the Henderson equation for a tight-binding inhibitor (see the Experimental section), which gave an inhibitory (dissociation) constant for CsA and CyP-D of 3 nM (Figure 2A, inset).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.67	19832699_47|19832699|6586|EXPERIMENTAL|0:0|Accordingly, kinetic data were analysed by the Henderson equation for a tight-binding, competitive inhibitor [22], which can be written:  where Eo and Io are the total concentrations of enzyme and inhibitor (cyclosporin) respectively, Ki is the enzyme inhibitor dissociation constant, Km is the Michaelis constant and [S] is the substrate concentration.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_4|19832699|20434|#section_info|0:0|Accordingly, inhibition was analysed using the Henderson equation for a tight-binding inhibitor (see the Experimental section), which gave an inhibitory (dissociation) constant for CsA and CyP-D of 3 nM (Figure 2A, inset).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.67	19832699_47|19832699|6586|EXPERIMENTAL|0:0|Accordingly, kinetic data were analysed by the Henderson equation for a tight-binding, competitive inhibitor [22], which can be written:  where Eo and Io are the total concentrations of enzyme and inhibitor (cyclosporin) respectively, Ki is the enzyme inhibitor dissociation constant, Km is the Michaelis constant and [S] is the substrate concentration.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_5|19832699|20434|#section_info|0:0|Additions to position-3 impaired binding slightly for SMBz-CsA (Figure 1), but strongly for mtCsA, where the binding affinity to CyP-D was approx. 30-fold lower than for CsA (Ki of 93 nM; Figure 2B).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_6|19832699|20434|#section_info|0:0|Additions to position-3 impaired binding slightly for SMBz-CsA (Figure 1), but strongly for mtCsA, where the binding affinity to CyP-D was approx. 30-fold lower than for CsA (Ki of 93 nM; Figure 2B).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_7|19832699|20434|#section_info|0:0|The binding affinities of CsA, SMBz-CsA and mtCsA to CyP-A were similar to those with CyP-D (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_8|19832699|20434|#section_info|0:0|The binding affinities of CsA, SMBz-CsA and mtCsA to CyP-A were similar to those with CyP-D (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_9|19832699|20434|#section_info|0:0|The binding affinities of CsA, SMBz-CsA and mtCsA to CyP-A were similar to those with CyP-D (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_10|19832699|20434|#section_info|0:0|The binding affinities of CsA, SMBz-CsA and mtCsA to CyP-A were similar to those with CyP-D (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_11|19832699|20434|#section_info|0:0|Additions to position-3 impaired binding slightly for SMBz-CsA (Figure 1), but strongly for mtCsA, where the binding affinity to CyP-D was approx. 30-fold lower than for CsA (Ki of 93 nM; Figure 2B).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_12|19832699|20434|#section_info|0:0|Additions to position-3 impaired binding slightly for SMBz-CsA (Figure 1), but strongly for mtCsA, where the binding affinity to CyP-D was approx. 30-fold lower than for CsA (Ki of 93 nM; Figure 2B).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_13|19832699|20434|#section_info|0:0|Additions to position-3 impaired binding slightly for SMBz-CsA (Figure 1), but strongly for mtCsA, where the binding affinity to CyP-D was approx. 30-fold lower than for CsA (Ki of 93 nM; Figure 2B).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_14|19832699|20434|#section_info|0:0|Additions to position-3 impaired binding slightly for SMBz-CsA (Figure 1), but strongly for mtCsA, where the binding affinity to CyP-D was approx. 30-fold lower than for CsA (Ki of 93 nM; Figure 2B).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_15|19832699|21314|#section_info|0:0|The PPIase activity of recombinant CyP-D was determined in the presence and absence of the given concentrations of (A) CsA and (B) mtCsA.|#fig_caption|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.65	19832699_141|19832699|22890|RESULTS|0:0|The phosphatase activity of calcineurin was measured in the presence and absence of CyP-A, CsA, SMBz-CsA and mtCsA at concentrations to give 720 nM complexes (see the Experimental section).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_165|19832699|27577|RESULTS|0:0|(B-D) Wild-type (WT) or CyP-D+ cells were incubated in the presence or absence of the indicated concentrations of CsA and mtCsA.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_22|19832699|3549|INTRODUCTION|0:0|CyP-D is a PPIase (peptidylprolyl cis-trans isomerase) that is located in the mitochondrial matrix [13] and is inhibited by CsA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_16|19832699|21314|#section_info|0:0|The PPIase activity of recombinant CyP-D was determined in the presence and absence of the given concentrations of (A) CsA and (B) mtCsA.|#fig_caption|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.65	19832699_141|19832699|22890|RESULTS|0:0|The phosphatase activity of calcineurin was measured in the presence and absence of CyP-A, CsA, SMBz-CsA and mtCsA at concentrations to give 720 nM complexes (see the Experimental section).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_165|19832699|27577|RESULTS|0:0|(B-D) Wild-type (WT) or CyP-D+ cells were incubated in the presence or absence of the indicated concentrations of CsA and mtCsA.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_22|19832699|3549|INTRODUCTION|0:0|CyP-D is a PPIase (peptidylprolyl cis-trans isomerase) that is located in the mitochondrial matrix [13] and is inhibited by CsA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_17|19832699|21678|#section_info|0:0|To enable comparisons, the concentrations of CsA, SMBz-CsA and mtCsA (at 0.9, 1 and 4 muM respectively) in the test incubations were chosen to establish the same concentrations (720 nM) of their respective complexes with CyP-A (calculated using the Ki values of CyP-A with CsA, SMBz-CsA and mtCsA; Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.67	19832699_141|19832699|22890|RESULTS|0:0|The phosphatase activity of calcineurin was measured in the presence and absence of CyP-A, CsA, SMBz-CsA and mtCsA at concentrations to give 720 nM complexes (see the Experimental section).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_169|19832699|27577|RESULTS|0:0|(E) CyP-D+ cells pretreated with CyP-A antisense oligodeoxynucleotide (AS; 42 h), 0.8 muM CsA, 2 muM SMBz-CsA or 2.4 muM mtCsA (for 10 min) were incubated with or without 100 muM nitroprusside (for 40 min) and extracts were assayed for caspase-3.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_18|19832699|21678|#section_info|0:0|To enable comparisons, the concentrations of CsA, SMBz-CsA and mtCsA (at 0.9, 1 and 4 muM respectively) in the test incubations were chosen to establish the same concentrations (720 nM) of their respective complexes with CyP-A (calculated using the Ki values of CyP-A with CsA, SMBz-CsA and mtCsA; Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.67	19832699_141|19832699|22890|RESULTS|0:0|The phosphatase activity of calcineurin was measured in the presence and absence of CyP-A, CsA, SMBz-CsA and mtCsA at concentrations to give 720 nM complexes (see the Experimental section).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_169|19832699|27577|RESULTS|0:0|(E) CyP-D+ cells pretreated with CyP-A antisense oligodeoxynucleotide (AS; 42 h), 0.8 muM CsA, 2 muM SMBz-CsA or 2.4 muM mtCsA (for 10 min) were incubated with or without 100 muM nitroprusside (for 40 min) and extracts were assayed for caspase-3.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_19|19832699|21678|#section_info|0:0|Figure 3 shows that, whereas CyP-A alone produced a small (20%) activation of calcineurin, the CsA-CyP-A complex inhibited calcineurin by approx. 70%.|#main_body|GO:0032513|negative regulation of protein phosphatase type 2B activity|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.64	19832699_228|19832699|34111|RESULTS|0:0|To investigate whether these effects, both protective (glutamate) and counterprotective (OGD), might involve inhibition of calcineurin by the CsA-CyP-A complex, we used FK506 (an immunosuppressant macrolide) which, as the FK506-FKBP (FK506-binding protein) complex, also inhibits calcineurin.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19832699_229|19832699|34111|RESULTS|0:0|As shown in Figure 8(B), FK506 partially reversed mtCsA-protection against OGD-induced necrosis, indicating that calcineurin inhibition is counterprotective.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_235|19832699|35459|RESULTS|0:0|To test whether the acute effectiveness of CsA against glutamate toxicity reflected a dual action in inhibiting both calcineurin and CyP-D (and the PT pore), we applied FK506 and mtCsA together; however this was no more effective than FK506 alone.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_247|19832699|41945|DISCUSSION|0:0|In addition, the CyP-A-CsA complex inhibits calcineurin, which dephosphorylates pro-apoptotic BAD (Bcl-2/Bcl-XL-antagonist, causing cell death) [37] and the L-type Ca2+ channel [38] in neurons.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_20|19832699|21678|#section_info|0:0|Figure 3 shows that, whereas CyP-A alone produced a small (20%) activation of calcineurin, the CsA-CyP-A complex inhibited calcineurin by approx. 70%.|#main_body|GO:0032513|negative regulation of protein phosphatase type 2B activity|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.64	19832699_228|19832699|34111|RESULTS|0:0|To investigate whether these effects, both protective (glutamate) and counterprotective (OGD), might involve inhibition of calcineurin by the CsA-CyP-A complex, we used FK506 (an immunosuppressant macrolide) which, as the FK506-FKBP (FK506-binding protein) complex, also inhibits calcineurin.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19832699_229|19832699|34111|RESULTS|0:0|As shown in Figure 8(B), FK506 partially reversed mtCsA-protection against OGD-induced necrosis, indicating that calcineurin inhibition is counterprotective.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_235|19832699|35459|RESULTS|0:0|To test whether the acute effectiveness of CsA against glutamate toxicity reflected a dual action in inhibiting both calcineurin and CyP-D (and the PT pore), we applied FK506 and mtCsA together; however this was no more effective than FK506 alone.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_247|19832699|41945|DISCUSSION|0:0|In addition, the CyP-A-CsA complex inhibits calcineurin, which dephosphorylates pro-apoptotic BAD (Bcl-2/Bcl-XL-antagonist, causing cell death) [37] and the L-type Ca2+ channel [38] in neurons.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_21|19832699|23149|#section_info|0:0|In the same system, CsA inhibited extramitochondrial CyP-A with a concentration profile similar to that of the PT pore (Figure 4B); this was expected given that CyP-D and CyP-A have similar binding affinities for CsA (Figure 1) and, being uncharged, CsA should equilibrate to the same free concentrations on either side of the inner membrane.|#main_body|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.67	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_190|19832699|30379|RESULTS|0:0|There was a relatively small protection with 0.1 muM CsA, but this was reversed at higher CsA concentrations, suggesting the existence of secondary CsA targets outside mitochondria that counteracted the protection.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19832699_269|19832699|45420|DISCUSSION|0:0|In agreement, and in line with other studies [27,40], we obtained evidence that calcineurin plays a major part in the pathogenesis of cell necrosis induced by glutamate; in particular, FK506 was protective (Figure 8A) and SMBz-CsA was less protective than CsA (Figure 9).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19832699_284|19832699|48729|DISCUSSION|0:0|In conclusion, we have developed a novel, mitochondrially targeted CsA and shown that it selectively inhibits the mitochondrial CyP-D-dependent PT pore compared with extramitochondrial CyP-A in intact cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_206|19832699|31746|RESULTS|0:0|Thus restricting the action of CsA to mitochondria with mtCsA largely removes protection by CsA, indicating that CsA attenuates glutamate toxicity by interacting with extramitochondrial CyPs, rather than intramitochondrial CyP-D.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_325|19832699|53655|FUNDING|0:0|The presence of two classes of high affinity cyclosporin binding sites in mitochondria Evidence that the minor component is involved in the opening of an inner-membrane, Ca2+-dependent pore|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_15|19832699|2194|INTRODUCTION|0:0|The non-specific PT pore [6], with an estimated internal diameter of 2 nm [1], allows free flow of low Mr solutes across the inner membrane.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_131|19832699|18978|RESULTS|0:0|[25] demonstrated that CsA may be specifically alkylated at the sarcosine-3 position if several equivalents of a strong base are used to generate a polyanion, and the same method was utilized here, as shown in Figure 1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_234|19832699|35459|RESULTS|0:0|Indeed, it is notable that both L-NAME and FK506 were less effective than CsA (Figure 8A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_235|19832699|35459|RESULTS|0:0|To test whether the acute effectiveness of CsA against glutamate toxicity reflected a dual action in inhibiting both calcineurin and CyP-D (and the PT pore), we applied FK506 and mtCsA together; however this was no more effective than FK506 alone.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_278|19832699|46995|DISCUSSION|0:0|Secondary, extramitochondrial targets of CsA presumably negate protection gained by PT inhibition as the CsA concentration is increased.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_22|19832699|23149|#section_info|0:0|In the same system, CsA inhibited extramitochondrial CyP-A with a concentration profile similar to that of the PT pore (Figure 4B); this was expected given that CyP-D and CyP-A have similar binding affinities for CsA (Figure 1) and, being uncharged, CsA should equilibrate to the same free concentrations on either side of the inner membrane.|#main_body|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.67	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19832699_190|19832699|30379|RESULTS|0:0|There was a relatively small protection with 0.1 muM CsA, but this was reversed at higher CsA concentrations, suggesting the existence of secondary CsA targets outside mitochondria that counteracted the protection.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19832699_269|19832699|45420|DISCUSSION|0:0|In agreement, and in line with other studies [27,40], we obtained evidence that calcineurin plays a major part in the pathogenesis of cell necrosis induced by glutamate; in particular, FK506 was protective (Figure 8A) and SMBz-CsA was less protective than CsA (Figure 9).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19832699_284|19832699|48729|DISCUSSION|0:0|In conclusion, we have developed a novel, mitochondrially targeted CsA and shown that it selectively inhibits the mitochondrial CyP-D-dependent PT pore compared with extramitochondrial CyP-A in intact cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_206|19832699|31746|RESULTS|0:0|Thus restricting the action of CsA to mitochondria with mtCsA largely removes protection by CsA, indicating that CsA attenuates glutamate toxicity by interacting with extramitochondrial CyPs, rather than intramitochondrial CyP-D.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_325|19832699|53655|FUNDING|0:0|The presence of two classes of high affinity cyclosporin binding sites in mitochondria Evidence that the minor component is involved in the opening of an inner-membrane, Ca2+-dependent pore|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_15|19832699|2194|INTRODUCTION|0:0|The non-specific PT pore [6], with an estimated internal diameter of 2 nm [1], allows free flow of low Mr solutes across the inner membrane.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_131|19832699|18978|RESULTS|0:0|[25] demonstrated that CsA may be specifically alkylated at the sarcosine-3 position if several equivalents of a strong base are used to generate a polyanion, and the same method was utilized here, as shown in Figure 1.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_234|19832699|35459|RESULTS|0:0|Indeed, it is notable that both L-NAME and FK506 were less effective than CsA (Figure 8A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_235|19832699|35459|RESULTS|0:0|To test whether the acute effectiveness of CsA against glutamate toxicity reflected a dual action in inhibiting both calcineurin and CyP-D (and the PT pore), we applied FK506 and mtCsA together; however this was no more effective than FK506 alone.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_278|19832699|46995|DISCUSSION|0:0|Secondary, extramitochondrial targets of CsA presumably negate protection gained by PT inhibition as the CsA concentration is increased.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_23|19832699|23149|#section_info|0:0|In contrast, mtCsA inhibited PT pore formation considerably better than it inhibited CyP-A (Figure 4D), even though it binds to CyP-A and CyP-D with similar affinities (Figure 1).|#main_body|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.64	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_24|19832699|23149|#section_info|0:0|In contrast, mtCsA inhibited PT pore formation considerably better than it inhibited CyP-A (Figure 4D), even though it binds to CyP-A and CyP-D with similar affinities (Figure 1).|#main_body|GO:0003755|peptidyl-prolyl cis-trans isomerase activity|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.64	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_25|19832699|23149|#section_info|0:0|In contrast, mtCsA inhibited PT pore formation considerably better than it inhibited CyP-A (Figure 4D), even though it binds to CyP-A and CyP-D with similar affinities (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.64	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_26|19832699|23149|#section_info|0:0|In contrast, mtCsA inhibited PT pore formation considerably better than it inhibited CyP-A (Figure 4D), even though it binds to CyP-A and CyP-D with similar affinities (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.64	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_27|19832699|23149|#section_info|0:0|This indicates that mtCsA was accumulated in the mitochondrial matrix, where CyP-D is located, in preference to the external medium, containing CyP-A.|#main_body|GO:0005759|mitochondrial matrix|#go_definition|NONE|GOA|CyP-D(361967)|#gene_synonym
0.69	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19832699_22|19832699|3549|INTRODUCTION|0:0|CyP-D is a PPIase (peptidylprolyl cis-trans isomerase) that is located in the mitochondrial matrix [13] and is inhibited by CsA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_28|19832699|23149|#section_info|0:0|This indicates that mtCsA was accumulated in the mitochondrial matrix, where CyP-D is located, in preference to the external medium, containing CyP-A.|#main_body|GO:0005759|mitochondrial matrix|#go_definition|NONE|GOA|Ppid(361967)|#gene_synonym
0.69	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19832699_22|19832699|3549|INTRODUCTION|0:0|CyP-D is a PPIase (peptidylprolyl cis-trans isomerase) that is located in the mitochondrial matrix [13] and is inhibited by CsA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_29|19832699|36131|#section_info|0:0|This was further investigated using SMBz-CsA, which inhibits CyP PPIase activity (Figure 1), but not calcineurin when in complex with CyP-A (Figure 3).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
0.61	19832699_234|19832699|35459|RESULTS|0:0|Indeed, it is notable that both L-NAME and FK506 were less effective than CsA (Figure 8A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_279|19832699|46995|DISCUSSION|0:0|These counterprotective targets may include calcineurin, as mtCsA-mediated protection was decreased by FK506 (Figure 8B), and SMBz-CsA was a better cytoprotectant than CsA (Figure 9).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_30|19832699|36131|#section_info|0:0|This was further investigated using SMBz-CsA, which inhibits CyP PPIase activity (Figure 1), but not calcineurin when in complex with CyP-A (Figure 3).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
0.61	19832699_234|19832699|35459|RESULTS|0:0|Indeed, it is notable that both L-NAME and FK506 were less effective than CsA (Figure 8A).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_279|19832699|46995|DISCUSSION|0:0|These counterprotective targets may include calcineurin, as mtCsA-mediated protection was decreased by FK506 (Figure 8B), and SMBz-CsA was a better cytoprotectant than CsA (Figure 9).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_31|19832699|38341|#section_info|0:0|Although differences in adjacent amino acids might offer potential for selective inhibition, the CsA-binding affinities of CyP-D and CyP-A are about the same (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
##EndOfRet##
19832699_32|19832699|38341|#section_info|0:0|Although differences in adjacent amino acids might offer potential for selective inhibition, the CsA-binding affinities of CyP-D and CyP-A are about the same (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
##EndOfRet##
19832699_33|19832699|38341|#section_info|0:0|Although differences in adjacent amino acids might offer potential for selective inhibition, the CsA-binding affinities of CyP-D and CyP-A are about the same (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-A(25518)|#gene_synonym
##EndOfRet##
19832699_34|19832699|38341|#section_info|0:0|Although differences in adjacent amino acids might offer potential for selective inhibition, the CsA-binding affinities of CyP-D and CyP-A are about the same (Figure 1).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppia(25518)|#gene_synonym
##EndOfRet##
19832699_35|19832699|39096|#section_info|0:0|For mtCsA, which bound with a 30-fold lower affinity to CyP-D compared with CsA, the matrix free-mtCsA concentration needed to block the PT will be 30-fold higher than for CsA, and unspecific binding to other components will be correspondingly greater.|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.61	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_36|19832699|39096|#section_info|0:0|For mtCsA, which bound with a 30-fold lower affinity to CyP-D compared with CsA, the matrix free-mtCsA concentration needed to block the PT will be 30-fold higher than for CsA, and unspecific binding to other components will be correspondingly greater.|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.61	19832699_87|19832699|13602|EXPERIMENTAL|0:0|The lower table shows the dissociation constants [determined as inhibitor constants (Ki) as described for Figure 2] for the binding of CsA and the CsA analogues to CyP-D and CyP-A.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_37|19832699|39096|#section_info|0:0|Thus the combination of decreased CyP-D-binding affinity, increased partitioning into membrane phospholipids, and unspecific binding may explain why more mtCsA than CsA was needed to inhibit the PT pore (Figures 4B and 4D).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|CyP-D(361967)|#gene_synonym
0.64	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_191|19832699|30379|RESULTS|0:0|Thus restricting the action of CsA to mitochondria using mtCsA improves its protective capacity against cell necrosis brought about by a period of OGD, indicating that CyP-D and the PT pore are major contributors to this form of injury.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19832699_38|19832699|39096|#section_info|0:0|Thus the combination of decreased CyP-D-binding affinity, increased partitioning into membrane phospholipids, and unspecific binding may explain why more mtCsA than CsA was needed to inhibit the PT pore (Figures 4B and 4D).|#main_body|GO:0016018|cyclosporin A binding|#go_definition|IDA|GOA|Ppid(361967)|#gene_synonym
0.64	19832699_281|19832699|46995|DISCUSSION|0:0|The augmented protective capacity of CsA against OGD-induced necrosis obtained by mitochondrial targeting cannot be explained by increased inhibition of mitochondrial CyP-D, as CsA was tested at concentrations (1 muM) sufficient to inhibit CyP-D completely (in B50 cells, 0.8 muM total CsA completely reversed the PT activation by CyP-D overexpression; Figure 5C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19832699_178|19832699|28570|RESULTS|0:0|Unlike CsA and SMBz-CsA, however, 2.4 muM mtCsA (which was sufficient to inhibit mitochondrial CyP-D; Figure 4D), had no significant effect on caspase activation, indicating that it was not accumulated in the cytosol, where CyP-A is located.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19832699_191|19832699|30379|RESULTS|0:0|Thus restricting the action of CsA to mitochondria using mtCsA improves its protective capacity against cell necrosis brought about by a period of OGD, indicating that CyP-D and the PT pore are major contributors to this form of injury.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
